Buswell Biomedical has been granted a patent by the United States Patent and Trademark Office (USPTO) for its rehabilitation mobility technology. The patent, which was issued after an extended review process, is a critical step in protecting the company’s intellectual property and securing its competitive edge in the market.
Sheila Buswell, CEO Buswell Biomedical
This “puts a moat around our technology so that our whole business is the control system, the secret sauce,” CEO Sheila Buswell told bizblip. She emphasized that securing the patent is the first step in a broader strategy to create a formidable barrier to entry for potential competitors.
Buswell Biomedical was founded in April 2019, and is headquartered in St. Louis Missouri. The young company is revolutionizing healthcare with its Upward Mobility (UPMO) device. Using advanced AI and sensor technology, the UPMO empowers rehabilitation patients to safely engage in independent activities, reducing the risk of falling, lawsuits and optimizing healthcare tasks.
The company’s innovative approach to mobility, which Buswell describes as the “secret sauce” to its growth, sets it apart in the marketplace. By leveraging cutting-edge technology, Buswell Biomedical aims to provide patients with an unparalleled level of independence and safety during their rehabilitation journey.
Buswell Biomedical has raised approximately $25,000 through grants and pitch competitions. However, the company has largely been self-funded. The startup is part of the 2023 InvestMidwest cohort, as well as a past participant in bizblip’s Pitches Get Stitches competition.
Links:
